地塞米松预防脂多糖诱导的大鼠回肠上皮屏障功能障碍
研究探讨低剂量地塞米松对内毒素血症大鼠肠道上皮屏障功能障碍的作用。大鼠在LPS诱导内毒素血症前1小时接受地塞米松0.1或1.0 mg/kg预处理,评估肠道通透性、细菌移位、细胞因子产生、组织学损伤及紧密连接蛋白定位与表达。内毒素血症大鼠表现为肠道上皮屏障功能障碍,包括通透性增加、细菌移位、紧密连接破坏及炎症反应过度激活。地塞米松预处理减轻全身和黏膜炎症介质产生,逆转LPS诱导的回肠损伤,增加occludin和claudin-1表达并降低claudin-2,同时保留组织学损伤和紧密连接形态、减少LPS诱导的紧密连接开放。
要点
- 大鼠LPS内毒素血症模型中,地塞米松0.1和1.0 mg/kg于LPS前1小时预处理可减轻肠道通透性增加和细菌移位。
- 地塞米松预处理减轻全身和黏膜炎症介质产生,并逆转LPS诱导的回肠组织学损伤。
- 地塞米松预处理增加回肠occludin和claudin-1表达、降低claudin-2表达,减少LPS诱导的紧密连接开放。
- 作者认为早期地塞米松治疗可打破内毒素血症中局部肠道炎症与屏障功能障碍的恶性循环。
适用人群与场景
- LPS诱导内毒素血症的大鼠模型,地塞米松于LPS给药前1小时预处理。
处置流程与药物剂量
- 地塞米松以0.1 mg/kg和1.0 mg/kg两个低剂量于LPS给药前1小时预处理大鼠。
研究设计与关键结果
- 研究为大鼠实验研究;LPS内毒素血症大鼠出现肠道上皮屏障功能障碍,表现为通透性增加、细菌移位、紧密连接破坏(开放及组成蛋白表达改变)和炎症反应过度激活。
- 地塞米松预处理(0.1和1.0 mg/kg,LPS前1小时)减轻全身和黏膜炎症介质产生,逆转LPS诱导的回肠损伤。
- 地塞米松预处理增加回肠occludin和claudin-1表达,降低claudin-2表达;组织学损伤和紧密连接形态得以保留,减少LPS诱导的紧密连接开放。
证据类型、等级与局限
- 证据类型:动物实验研究(大鼠)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为早期地塞米松治疗可打破内毒素血症中局部肠道炎症与屏障功能障碍的恶性循环,尤其保护单层上皮的关键结构紧密连接。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Inflammatory mediators have been postulated as elementary inducing factors to the disruption of the intestinal tight junctions (TJ) and consequently, gut permeability and bacterial translocation. Corticosteroids are considered the mainstay in the treatment of septic shock; however, the impact of this therapy on the intestinal epithelial barrier dysfunction during septic shock remains unknown. Our aims were to demonstrate the role of low dexamethasone (DEX) doses in modulation of the inflammatory response, as well as the expression and the arrangement of TJ proteins in endotoxemic rats. One hour before the endotoxemia induction by lipopolysaccharide (LPS) administration, rats were pretreated with DEX at two low-doses (0.1 and 1.0 mg/kg). The parameters assessed included intestinal permeability, bacterial translocation, cytokines production, histology injury, localization, and expression of TJ proteins. Endotoxemic rats displayed intestinal epithelial barrier dysfunction, characterized by increased permeability and bacterial translocation, TJ disruption (opening and changes to its constituent proteins expression) and hyperactivation of the inflammatory response. On the other hand, the pretreatment with DEX attenuated the systemic and mucosal production of inflammatory mediators and also reverted the LPS-induced ileal injuries, increasing the expression of occludin and claudin-1, but also reducing claudin-2. Moreover, the histological damages and the morphology of the TJ were preserved by the DEX administration, therefore reducing their LPS-induced opening. The present study sheds light on the fact that early DEX treatment breaks the vicious cycle of local gut inflammation and barrier dysfunction in endotoxemia, especially preserving an essential structure of this monolayer epithelium, the TJ.
参考来源
- Ribeiro AB, Giusti H, Souza APT, et al. Dexamethasone Prevents Lipopolysaccharide-Induced Epithelial Barrier Dysfunction in Rat Ileum. Shock. 2018. PMID: 28650927. doi:10.1097/SHK.0000000000000930
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。